Gomisin A ameliorates metastatic melanoma by inhibiting AMPK and ERK/JNK-mediated cell survival and metastatic phenotypes. [electronic resource]
Producer: 20200511Description: 153147 p. digitalISSN:- 1618-095X
- AMP-Activated Protein Kinases -- antagonists & inhibitors
- Animals
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis -- drug effects
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Cyclooctanes -- pharmacology
- Dioxoles -- pharmacology
- Epithelial-Mesenchymal Transition -- drug effects
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Humans
- Lignans -- pharmacology
- Lung Neoplasms -- drug therapy
- MAP Kinase Kinase 4 -- metabolism
- Melanoma -- drug therapy
- Mice, Inbred C57BL
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.